![]() ![]() We also make sure that our pet parents are educated on the best ways to avoid flea and tick infestations in their homes as well as on their pets. At Tierrasanta Veterinary Hospital, flea and tick prevention is something that we deal with routinely, so we are experts at administering effective treatments. We’ve dealt with tick disease and I take it seriously, but I would choose other products and would never use any of these again.If you’re searching for a veterinarian in San Diego who can help you with flea and tick prevention, our Tierrasanta vet can quickly examine your pet and advise you on the best types of treatments that can keep your pet flea and tick free. Pet owners have a right to be adequately warned, the the FDA has a responsibility to both notify us and if necessary review the safety of products on the market to protect consumers and our pets. I’ve spoken with others who have lost young dogs, puppies, and adults, or who are dealing with the long term aftereffects. My own dog experienced this and we lost her after months of seizures and loss of motor control that broke my heart. Not all dogs react but some dogs have serious reactions that lead to permanent damage or death. The FDA has required that the warnings in the packaging be reworded to reflect the recognized neurologic risks. In response to earlier comments, there is nothing inflammatory about the information or wording in this article. The facts are that the FDA has issued warnings since 2018 and again in 2019 about the neurologic events from isoxazoline pesticide treatments and chews. ![]() Pet owners and veterinarians who have additional questions can contact or call 24. To report suspected adverse drug events for these products and/or obtain a copy of the Safety Data Sheet (SDS) or for technical assistance, contact the appropriate manufacturers at the following phone numbers: You can do this by reporting to the drugs’ manufacturers, who are required to report this information to the FDA, or by submitting a report directly to the FDA. The FDA continues to monitor adverse drug event reports for these products and encourages pet owners and veterinarians to report adverse drug events. Veterinarians should use their specialized training to review their patients’ medical histories and determine, in consultation with pet owners, whether a product in the isoxazoline class is appropriate for the pet. The agency is asking the manufacturers to make the changes to the product labeling in order to provide veterinarians and pet owners with the information they need to make treatment decisions for each pet on an individual basis. The FDA carefully reviewed studies and other data on Bravecto, Credelio, Nexgard and Simparica prior to approval, and these products continue to be safe and effective for the majority of animals. The FDA is working with manufacturers of isoxazoline products to include new label information to highlight neurologic events because these events were seen consistently across the isoxazoline class of products. ![]() These products are approved for the treatment and prevention of flea infestations, and the treatment and control of tick infestations. Another product in this class, Credelio, recently received FDA approval. Since these products obtained their respective FDA approvals, data received by the agency as part of its routine post-marketing activities indicates that some animals receiving Bravecto, Nexgard or Simparica have experienced adverse events such as muscle tremors, ataxia, and seizures. #FLEA AND TICK MEDICINE PLUS#Pet owners using flea and tick medications in the isoxazoline class – specifically Bravecto (tablets for dogs OR topical for dogs or cats), Nexgard (tablets for dogs) or Simparica (tablets for dogs), Credelio (tablets for dogs) and Revolution Plus (topical solution for cats) – are urged to closely monitor their pets for adverse neurologic events. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |